Skip to main content
Complete Olympic Games coverage at your fingertips
Your inside track on the Olympic Games
Enjoy unlimited digital access
$1.99
per week for 24 weeks
Complete Olympic Games coverage at your fingertips
Your inside track onthe Olympics Games
$1.99
per week
for 24 weeks
// //

Biontech Se ADR NASDAQ: BNTX-Q

Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time

More stories below advertisement

Latest Press Releases

BioNTech Completes Acquisition of Kite's Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland
- Business Wire - Wed Aug 4, 6:00AM CDT
Business Wire - CMTX
Wed Aug 4, 6:00AM CDT
BioNTech SE (Nasdaq: BNTX, "BioNTech") and Kite, a Gilead Company (Nasdaq: GILD, "Kite") today announced the closing of the acquisition of the solid tumor neoantigen T cell receptor (TCR) R&D platform and clinical manufacturing facility's assets and leases in Gaithersburg, MD, from Kite. The transaction was announced on July 19, 2021.
The Covid Vaccine Market is a Long Game in the Early Innings (BNTX, AZN, DYAI, NVAX, MRNA, PFE, JNJ)
- WallStreetPR - Wed Aug 4, 12:51AM CDT
WallStreetPR - CMTX
Wed Aug 4, 12:51AM CDT
Dyadic Int'l (DYAI) Inks Deal Toward Potential Access to 40% of the World as Covid Vaccine Continues in Development
- WallStreetPR - Wed Jul 28, 7:30AM CDT
WallStreetPR - CMTX
Wed Jul 28, 7:30AM CDT
Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
- Globe Newswire - Fri Jul 23, 5:45AM CDT
Globe Newswire - CMTX
Fri Jul 23, 5:45AM CDT
- Dose deliveries for new order expected to occur from October 2021 through April 2022
Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
- Business Wire - Fri Jul 23, 5:45AM CDT
Business Wire - CMTX
Fri Jul 23, 5:45AM CDT
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. government has purchased an additional 200 million doses of the Pfizer-BioNTech COVID-19 Vaccine. These doses are expected to be delivered from October 2021 through April 2022. This brings the total number of doses to be supplied by the companies to the U.S. government under its existing supply agreement to 500 million. In a separate announcement on June 10, 2021, Pfizer and BioNTech shared plans to provide the U.S. government with 500 million doses of the companies' COVID-19 vaccine for donation to the world's poorest nations.
Delta Variant Infections of COVID Rising Quickly & Now Responsible for 83% of All U.S. Cases
- PR Newswire - PRF - Thu Jul 22, 8:30AM CDT
PR Newswire - PRF - CMTX
Thu Jul 22, 8:30AM CDT
PALM BEACH, Fla., /PRNewswire/ -- According to WebMD, this week the nation's top health officials  Tuesday that the Delta variant of the coronavirus is racing through and other parts of the world and now is responsible for 83% of all U.S. cases alone. That's a massive increase from a week ago, when Delta was seen as responsible for just more than half of new cases, CDC Director , MD, told a Senate committee. "The best way to prevent the spread of COVID-19 variants is to prevent the spread of disease, and vaccination is the most powerful tool we have," she said. Meanwhile, several states in the South are reporting a large increase in COVID-19 cases, particularly in areas with low vaccination rates, according , , and are reporting full-fledged outbreaks, and neighboring states such as , , , , , and are following behind.  to the National Institutes of Health (NIH): "When variants of SARS-CoV-2 (the virus that causes COVID-19) emerged in late 2020, concern arose that they might elude protective immune responses generated by prior infection or vaccination, potentially making re-infection more likely or vaccination less effective. To investigate this possibility, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and colleagues analyzed blood cell samples from 30 people who had contracted and recovered from COVID-19 prior to the emergence of virus variants. They found that one key player in the immune response to SARS-CoV-2—the CD8+ T cell—remained active against the virus."  Active biotech companies in the market this week include (OTCQB: BVAXF) (CSE: BIOV), . (NYSE: PFE), (NYSE: JNJ), (NASDAQ: MRNA), (NASDAQ: SRNE).
Delta Means Beta Testing Alpha Strategies in Biotech (NVAX, MRNA, DYAI, PFE, JNJ, BNTX, AZN, IBB)
- WallStreetPR - Thu Jul 22, 7:07AM CDT
WallStreetPR - CMTX
Thu Jul 22, 7:07AM CDT
Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa
- Business Wire - Wed Jul 21, 6:15AM CDT
Business Wire - CMTX
Wed Jul 21, 6:15AM CDT
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent with The Biovac Institute (Pty) Ltd, known as "Biovac," a Cape Town-based, South African biopharmaceutical company, to manufacture the Pfizer-BioNTech COVID-19 Vaccine for distribution within the African Union.
BioNTech to Acquire Kite's Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD
- Business Wire - Mon Jul 19, 7:00AM CDT
Business Wire - CMTX
Mon Jul 19, 7:00AM CDT
-- Kite Remains Focused on Rapid Advancement of Current CAR T-Cell Therapies to Reach More Patients and Further Optimize Therapeutic Potential of Cell Therapy --
Thinking about trading options or stock in Moderna, AMC Entertainment, BioNTech, Intel Corp, or Apple?
- PR Newswire - PRF - Fri Jul 16, 8:31AM CDT
PR Newswire - PRF - CMTX
Fri Jul 16, 8:31AM CDT
/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRNA, AMC, BNTX, INTC, and AAPL.

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies